Mind, Mood and Microbiota—Gut–Brain Axis in Psychiatric Disorders

Corneliu Toader,Nicolaie Dobrin,Daniel Costea,Luca-Andrei Glavan,Razvan-Adrian Covache-Busuioc,David-Ioan Dumitrascu,Bogdan-Gabriel Bratu,Horia-Petre Costin,Alexandru Vlad Ciurea

DOI: https://doi.org/10.3390/ijms25063340

IF: 5.6

2024-03-15

International Journal of Molecular Sciences

Abstract:Psychiatric disorders represent a primary source of disability worldwide, manifesting as disturbances in individuals' cognitive processes, emotional regulation, and behavioral patterns. In the quest to discover novel therapies and expand the boundaries of neuropharmacology, studies from the field have highlighted the gut microbiota's role in modulating these disorders. These alterations may influence the brain's processes through the brain–gut axis, a multifaceted bidirectional system that establishes a connection between the enteric and central nervous systems. Thus, probiotic and prebiotic supplements that are meant to influence overall gut health may play an insightful role in alleviating psychiatric symptoms, such as the cognitive templates of major depressive disorder, anxiety, or schizophrenia. Moreover, the administration of psychotropic drugs has been revealed to induce specific changes in a microbiome's diversity, suggesting their potential utility in combating bacterial infections. This review emphasizes the intricate correlations between psychiatric disorders and the gut microbiota, mentioning the promising approaches in regard to the modulation of probiotic and prebiotic treatments, as well as the antimicrobial effects of psychotropic medication.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

This paper discusses the relationship between gut microbiota and mental disorders, especially how they affect mental health through the gut-brain axis. Studies indicate that gut microbiota may play an important role in conditions such as depression and anxiety disorders, potentially influencing brain function through the regulation of neurotransmitters and the immune system. The paper also mentions probiotics and prebiotics as potential therapeutic strategies, as well as the impact of antipsychotic medications on gut microbiota diversity. Furthermore, it discusses how imbalances in gut microbiota may lead to psychopathology and emphasizes the role of interactions between the microbiome, immune system, neurotransmitters, and brain metabolites in the pathogenesis of mental disorders. In conclusion, this study aims to deepen the understanding of the link between gut health and mental health and explore novel treatment approaches.